CD44 and neoplasm: As our previous study showed that VDAC1-tumor depletion eliminated CSCs [18,47], the tumors treated with si-NT or with si-m/hVDAC1-B were analyzed for the expression levels of CSC markers CD133 and CD44 in SCLC [48].